Implantable extravascular electrical stimulation lead having improved sensing and pacing capability
US-2015306410-A1 · Oct 29, 2015 · US
US9936890B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9936890-B2 |
| Application number | US-201514926419-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2015 |
| Priority date | Feb 18, 2015 |
| Publication date | Apr 10, 2018 |
| Grant date | Apr 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An implantable medical device and method for determining an atrial arrhythmia event that includes a cardiac sensing device comprising a housing having circuitry positioned therein, a plurality of electrodes electrically coupled to the circuitry to sense a cardiac signal, and a processor configured to generate an initial detection of an atrial arrhythmia event in response to an atrial arrhythmia threshold, determine whether a P-wave occurs during the initial detection, determine an adaptive threshold in response to the P-wave being detected, adjust the atrial arrhythmia threshold in response to the adaptive threshold, and generate a subsequent initial detection of an atrial arrhythmia event using the adjusted atrial arrhythmia threshold.
Opening claim text (preview).
We claim: 1. An implantable medical device for determining an atrial arrhythmia event, comprising: a cardiac sensing device comprising a housing having circuitry positioned therein; a plurality of electrodes electrically coupled to the circuitry to sense a cardiac signal; and a processor configured to generate an initial detection of an atrial arrhythmia event in response to an atrial arrhythmia threshold, determine whether a P-wave is detected during the initial detection, identify the initial detection as a false positive detection in response to a P-wave being detected, determine an adaptive threshold in response to the P-wave being detected, adjust the atrial arrhythmia threshold in response to the adaptive threshold, and generate a subsequent detection of an atrial arrhythmia event using the adjusted atrial arrhythmia threshold. 2. The implantable medical device of claim 1 , wherein the atrial arrhythmia event comprises an atrial fibrillation event. 3. The implantable medical device of claim 1 , wherein the processor is further configured to increment an adjustment count in response to the initial detection being identified as a false positive detection, and determine the adaptive threshold in response to the adjustment count. 4. The implantable medical device of claim 3 , wherein the processor is further configured to set the adaptive threshold equal to a ratio of the adjustment count and a tuning factor corresponding to a desired level of aggressiveness for rejecting inappropriate determinations of the atrial arrhythmia event. 5. The implantable medical device of claim 3 , wherein the processor is configured to determine whether the adaptive threshold is greater than a maximum adaptive threshold, and add the adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold not being greater than the maximum adaptive threshold. 6. The implantable medical device of claim 5 , wherein the processor is configured to set the adaptive threshold equal to the maximum adaptive threshold and add the maximum adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold being greater than the maximum adaptive threshold. 7. The implantable medical device of claim 1 , wherein the processor is configured to confirm the initial determination of the atrial arrhythmia event in response to a P-wave not being detected, determine whether a duration of the detected atrial arrhythmia event is greater than a duration threshold, and set the adjustment count to zero in response to the duration of the detected atrial arrhythmia event being greater than the duration threshold. 8. The implantable medical device of claim 7 , wherein the processor is configured to determine an RR-interval variation associated with the sensed cardiac signal, determine an atrial arrhythmia score in response the RR-interval variation, determine whether the score is greater than the atrial arrhythmia threshold, increment a normal sinus count, determine whether the normal sinus count is greater than a normal sinus count threshold, and set the adjustment count to zero in response to the normal sinus count being greater than the normal sinus count threshold. 9. The implantable medical device of claim 8 , wherein the processor is further configured to increment an adjustment count in response to the initial detection being identified as a false positive detection, and determine the adaptive threshold in response to the adjustment count. 10. The implantable medical device of claim 9 , wherein the processor is further configured to set the adaptive threshold equal to a ratio of the adjustment count and a tuning factor corresponding to a desired level of aggressiveness for rejecting inappropriate determinations of the atrial arrhythmia event. 11. The implantable medical device of claim 10 , wherein the processor is configured to determine whether the adaptive threshold is greater than a maximum adaptive threshold, and add the adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold not being greater than the maximum adaptive threshold. 12. The implantable medical device of claim 11 , wherein the processor is configured to set the adaptive threshold equal to the maximum adaptive threshold and add the maximum adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold being greater than the maximum adaptive threshold. 13. The implantable medical device of claim 12 , wherein the atrial arrhythmia event comprises an atrial fibrillation event. 14. The implantable medical device of claim 1 , wherein the atrial arrhythmia event comprises an atrial tachycardia event. 15. A method of determining an atrial arrhythmia event in an implantable medical device, comprising: sensing a cardiac signal; generating an initial detection of an atrial arrhythmia event in response to an atrial arrhythmia threshold; determining whether a P-wave is detected during the initial detection; identifying the initial detection as a false positive detection in response to a P-wave being detected; determining an adaptive threshold in response to the P-wave being detected; adjusting the atrial arrhythmia threshold in response to the adaptive threshold; and generating a subsequent detection of an atrial arrhythmia event using the adjusted atrial arrhythmia threshold. 16. The method of claim 15 , wherein the atrial arrhythmia event comprises an atrial fibrillation event. 17. The method of claim 15 , further comprising: incrementing an adjustment count in response to the initial detection being identified as a false positive detection; and determining the adaptive threshold in response to the adjustment count. 18. The method of claim 17 , further comprising setting the adaptive threshold equal to a ratio of the adjustment count and a tuning factor corresponding to a desired level of aggressiveness for rejecting inappropriate determinations of the atrial arrhythmia event. 19. The method of claim 17 , further comprising: determining whether the adaptive threshold is greater than a maximum adaptive threshold; and adding the adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold not being greater than the maximum adaptive threshold. 20. The method of claim 19 , further comprising: setting the adaptive threshold equal to the maximum adaptive threshold; and adding the maximum adaptive threshold to the atrial arrhythmia threshold in response to the adaptive threshold being greater than the maximum adaptive threshold. 21. The method of claim 15 , further comprising: confirming the initial determination of the atrial arrhythmia event in response to a P-wave not being detected; determining whether a duration of the detected atrial arrhythmia event is greater than a duration threshold; and setting the adjustment count to zero in response to the duration of the detected atrial arrhythmia event being greater than the duration threshold. 22. The method of claim 15 , further comprising: determining an RR-interval variation associated with the sensed cardiac signal; determining an atrial arrhythmia score in response the RR-interval variation; determining whether the score is greater than the atrial arrhythmia threshold; incrementing a normal sinus count; determining whether the normal sinus count is greater than a normal sinus count threshold; and setting the adjustment count to zero in resp
for treating atrial fibrillation · CPC title
Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence) · CPC title
controlled by the heart rate variability · CPC title
characterised by the timing or triggering of the shock · CPC title
controlled by gradient or slope of the heart potential · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.